Conclusion
tumor, HCC
HEPATOCELLULAR CARCINOMA, TUMOR, RECURRENCE
The present study proposed two nomogram models integrating presurgical CTC counts and clinicopathological risks and showed relatively good predictive performance of EHR, which may be beneficial to the clinical practice of HCC recurrence. Further multicenter studies are needed to assess its general applicability.This study aimed to develop and assess nomogram models prediction of postsurgical extrahepatic recurrence (EHR) in patients with hepatocellular carcinoma. This study developed and assessed the performance of predictive models via presurgical circulating tumor cell data analysis and multiple clinicopathological features in patients with a high risk of developing EHR.
Hao‐Wen Wei and Shui‐Ling Qin contributed equally to this work.